Skip to main content

JPMORGAN CHASE & CO

Position in CRVS — Corvus Pharmaceuticals, Inc.

CIK 19617 NEW YORK, NY

Position in CRVS

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$2,121,269
+$1,885,227 QoQ
Shares Held
141,986
+363.2% QoQ
Ownership
0.169%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#51
of 172 holders
Holding Since
Mar 2022
16 quarters on record
Voting authority Sole 75% Shared 0% None 25%

Common Shares in CRVS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $12,920,143,124 across 425 Biotechnology names. CRVS ranks #149 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CRVS

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,121,269 141,986
2025-12-31 $236,042 30,655
2025-09-30 $237,548 32,232
2025-06-30 $121,680 30,420
2025-03-31 $15,069 4,739
2024-12-31 $130,833 24,455
2024-09-30 $261,655 49,556
2024-06-30 $16,655 9,152
2024-03-31 $94,026 52,824
2023-12-31 $1,194 679
2023-09-30 $102,063 69,907
2023-06-30 $2,750 1,201
2022-12-31 $1,020 1,201
2022-09-30 $2,281 2,786
2022-06-30 $1,948 1,968
2022-03-31 $9,018 5,499